香港六合彩开奖结果

Vol. 19 No. 1 (2020)
Clinical Cases

Female patient with erythoderma, mucositis and pancytopenia

Natasha Cytrynbaum
Programa de Resid锚ncia em Cl铆nica M茅dica. Departamento de Cl铆nica M茅dica. Faculdade de Ci锚ncias M茅dicas. Universidade do Estado do Rio de Janeiro, RJ, Brasil.
Andr茅 P. G. Machado
. Departamento de Cl铆nica M茅dica. Faculdade de Ci锚ncias M茅dicas. Universidade do Estado do Rio de Janeiro, RJ, Brasil.
DOI:

Published 2020-07-01

Keywords

  • Erythroderma,
  • Mucositis,
  • Pancytopenia,
  • Methotrexate,
  • Pharmacodermia

How to Cite

1.
Natasha Cytrynbaum, Andr茅 P. G. Machado. Female patient with erythoderma, mucositis and pancytopenia. BJHBS [Internet]. 2020 Jul. 1 [cited 2024 Oct. 12];19(1):69-73. Available from: /bjhbs/article/view/115
Crossref
Scopus

Abstract

A 31 year-old female patient with psoriasis on irregular treatment with methotrexate, folic acid, and cyclosporine presenting erythroderma associated with epidermal desquamation, mucositis and pancytopenia was admitted for investigation.

Metrics

Metrics Loading ...

References

  1. Pal S, Haroon TS. Erythroderma: a clinico-etiologic study of 90 cases. Int J Dermatol. 1998;37:104.
  2. Klein A, Landthaler M, Karrer S. Pityriasis rubra pilaris: a review of diagnosis and treatment. Am J Clin Dermatol. 2010;11:157.
  3. Aringer M, Costenbader K, Daikh D, et al. 2019 European League Against Rheumatism/American College of Rheumatology classifcation criteria for systemic lupus erythematosus. Ann Rheum Dis. 2019;78:1151.
  4. Olsen E, Vonderheid E, Pimpinelli N, et al. Revisions to the staging and classifcation of mycosis fungoides and Sezary syndrome: a proposal of the International Society for Cutaneous Lymphomas (ISCL) and the cutaneous lymphoma task force of the European Organization of Research and Treatment of Cancer (EORTC). Blood. 2007; 110:1713.
  5. Akhyani M, Ghodsi ZS, Toosi S, et al. Erythroderma: a clinical study of 97 cases. BMC Dermatol. 2005;5:5.
  6. Martins GA, Arruda L. Tratamento sist锚mico da psor铆ase - Parte I: metotrexato e acitretina. An Bras Dermatol. 2004;79(3):263-278.
  7. Izraeli S, Vora A, Zwaan CM, et al. How I treat ALL in Down鈥檚 syndrome: pathobiology and management. Blood. 2014;123:35.
  8. Ata铆de DST, Esmanhoto LDK, Helmer KA, et al. Ulcera莽茫o das placas psori谩ticas - efeito cut芒neo adverso do metotrexato em altas doses no tratamento da psor铆ase: relato de tr锚s casos. An Bras Dermatol. 2003;78:749-53.
  9. Mockenhaupt M, Dunant A, Paulmann M, et al. Drug Causality in Stevens鈥怞ohnson Syndrome / Toxic Epidermal Necrolysis in Europe: Analysis of 10 Years RegiSCAR鈥怱tudy. Pharmacoepidemiol Drug Saf. 2016;25(Supp 3):3. 10. Mockenhaupt M, Viboud C, Dunant A, et al. Stevens-Johnson syndrome and toxic epidermal necrolysis: assessment of medication risks with emphasis on recently marketed drugs. The EuroSCAR-study. J Invest Dermatol. 2008;128:35.